Alyeska Investment Group, L.P. - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 37 filers reported holding LIANBIO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of LIANBIO
ValueSharesWeighting
Q3 2022$858,000
+20.7%
429,186
+30.4%
0.01%
+25.0%
Q2 2022$711,000
-43.5%
329,186
-3.0%
0.01%
-42.9%
Q1 2022$1,259,000
-28.3%
339,242
+19.1%
0.01%
-30.0%
Q4 2021$1,755,000284,8500.02%
Other shareholders
LIANBIO shareholders Q4 2021
NameSharesValueWeighting ↓
SCHF (GPE), LLC 937,500$1,39725.49%
Vida Ventures Advisors, LLC 2,282,084$3,400,3055.26%
Perceptive Advisors 57,558,451$85,762,0912.86%
22NW, LP 2,211,678$3,295,4002.35%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,303,573$4,922,3240.69%
TANG CAPITAL MANAGEMENT LLC 1,800,000$2,682,0000.38%
Affinity Asset Advisors, LLC 672,357$1,001,8120.28%
MYDA Advisors LLC 200,000$298,0000.10%
Logos Global Management LP 280,000$417,2000.06%
Old Well Partners, LLC 32,200$47,9780.04%
View complete list of LIANBIO shareholders